Decline of RSV-specific antibodies during the COVID-19 pandemic

Lifting these measures resulted in out-of-season RSV activity, sometimes exceeding the incidence of hospitalisations observed in regular seasons.1–3 Declining immunity due to reduced exposure to the virus may contribute to this altered epidemiology.1,4,5 Bardsley and colleagues1 showed that the comb...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2023-01, Vol.23 (1), p.23-25
Main Authors: den Hartog, Gerco, van Kasteren, Puck B, Schepp, Rutger M, Teirlinck, Anne C, van der Klis, Fiona R M, van Binnendijk, Robert S
Format: Article
Language:English
Subjects:
Age groups
Antibodies
Antibodies, Neutralizing
Coronaviruses
COVID-19
Epidemiology
Humans
Immunity
Infectious diseases
Laboratories
Pandemics
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus, Human
Seasons
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93
cites cdi_FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93
container_end_page 25
container_issue 1
container_start_page 23
container_title The Lancet infectious diseases
container_volume 23
creator den Hartog, Gerco
van Kasteren, Puck B
Schepp, Rutger M
Teirlinck, Anne C
van der Klis, Fiona R M
van Binnendijk, Robert S
description Lifting these measures resulted in out-of-season RSV activity, sometimes exceeding the incidence of hospitalisations observed in regular seasons.1–3 Declining immunity due to reduced exposure to the virus may contribute to this altered epidemiology.1,4,5 Bardsley and colleagues1 showed that the combination of laboratory, clinical, and syndromic data capture the impact of RSV activity, yet did not provide insight into the proposed decline in immunity. The repeated-measures general linear model (SPSS version 28; IBM, Armonk, NY, USA) was used to compare antibody concentrations between sampling timepoints of the same subjects and between age groups. p values, adjusted to Bonferroni and Benjamini-Hochberg procedures, are reported for timepoints and age-group differences respectively. [...]monitoring changes in antibody concentrations could identify populations susceptible to RSV infection.
doi_str_mv 10.1016/S1473-3099(22)00763-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2747007358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309922007630</els_id><sourcerecordid>2755787694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93</originalsourceid><addsrcrecordid>eNqFkMlKBDEQhoMo7o-gNHgZD62VvXMSGVcQBLdr6ElXNDLTPSbdgm9vnFEPXjxVUXx_VfERskfhiAJVx_dUaF5yMGbE2CGAVryEFbKZx6IUQurVRb9ENshWSq8AVFMQ62SDK6F4ZdgmOTlDNw0tFp0v7u6fyjRHF3xwRd32YdI1AVPRDDG0z0X_gsX49un6rKSmmNdtg7Pgdsiar6cJd7_rNnm8OH8YX5U3t5fX49Ob0gkBfamdqaSRnE4AvALOvANDmRNYcc9BS29M5RWCkw312klVKSZAcDQN1Wj4Nhkt985j9zZg6u0sJIfTad1iNyTLtNBZApdVRg_-oK_dENv8Xaak1JVWRmRKLikXu5QiejuPYVbHD0vBfhm2C8P2S59lzC4MW8i5_e_tw2SGzW_qR2kGTpYAZh3vAaNNLmDrsAkRXW-bLvxz4hOvMoaX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2755787694</pqid></control><display><type>article</type><title>Decline of RSV-specific antibodies during the COVID-19 pandemic</title><source>Elsevier</source><creator>den Hartog, Gerco ; van Kasteren, Puck B ; Schepp, Rutger M ; Teirlinck, Anne C ; van der Klis, Fiona R M ; van Binnendijk, Robert S</creator><creatorcontrib>den Hartog, Gerco ; van Kasteren, Puck B ; Schepp, Rutger M ; Teirlinck, Anne C ; van der Klis, Fiona R M ; van Binnendijk, Robert S</creatorcontrib><description>Lifting these measures resulted in out-of-season RSV activity, sometimes exceeding the incidence of hospitalisations observed in regular seasons.1–3 Declining immunity due to reduced exposure to the virus may contribute to this altered epidemiology.1,4,5 Bardsley and colleagues1 showed that the combination of laboratory, clinical, and syndromic data capture the impact of RSV activity, yet did not provide insight into the proposed decline in immunity. The repeated-measures general linear model (SPSS version 28; IBM, Armonk, NY, USA) was used to compare antibody concentrations between sampling timepoints of the same subjects and between age groups. p values, adjusted to Bonferroni and Benjamini-Hochberg procedures, are reported for timepoints and age-group differences respectively. [...]monitoring changes in antibody concentrations could identify populations susceptible to RSV infection.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(22)00763-0</identifier><identifier>PMID: 36463892</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Age groups ; Antibodies ; Antibodies, Neutralizing ; Coronaviruses ; COVID-19 ; Epidemiology ; Humans ; Immunity ; Infectious diseases ; Laboratories ; Pandemics ; Respiratory syncytial virus ; Respiratory Syncytial Virus Infections - epidemiology ; Respiratory Syncytial Virus, Human ; Seasons</subject><ispartof>The Lancet infectious diseases, 2023-01, Vol.23 (1), p.23-25</ispartof><rights>2023 Elsevier Ltd</rights><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93</citedby><cites>FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36463892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>den Hartog, Gerco</creatorcontrib><creatorcontrib>van Kasteren, Puck B</creatorcontrib><creatorcontrib>Schepp, Rutger M</creatorcontrib><creatorcontrib>Teirlinck, Anne C</creatorcontrib><creatorcontrib>van der Klis, Fiona R M</creatorcontrib><creatorcontrib>van Binnendijk, Robert S</creatorcontrib><title>Decline of RSV-specific antibodies during the COVID-19 pandemic</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Lifting these measures resulted in out-of-season RSV activity, sometimes exceeding the incidence of hospitalisations observed in regular seasons.1–3 Declining immunity due to reduced exposure to the virus may contribute to this altered epidemiology.1,4,5 Bardsley and colleagues1 showed that the combination of laboratory, clinical, and syndromic data capture the impact of RSV activity, yet did not provide insight into the proposed decline in immunity. The repeated-measures general linear model (SPSS version 28; IBM, Armonk, NY, USA) was used to compare antibody concentrations between sampling timepoints of the same subjects and between age groups. p values, adjusted to Bonferroni and Benjamini-Hochberg procedures, are reported for timepoints and age-group differences respectively. [...]monitoring changes in antibody concentrations could identify populations susceptible to RSV infection.</description><subject>Age groups</subject><subject>Antibodies</subject><subject>Antibodies, Neutralizing</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Immunity</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Pandemics</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory Syncytial Virus Infections - epidemiology</subject><subject>Respiratory Syncytial Virus, Human</subject><subject>Seasons</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkMlKBDEQhoMo7o-gNHgZD62VvXMSGVcQBLdr6ElXNDLTPSbdgm9vnFEPXjxVUXx_VfERskfhiAJVx_dUaF5yMGbE2CGAVryEFbKZx6IUQurVRb9ENshWSq8AVFMQ62SDK6F4ZdgmOTlDNw0tFp0v7u6fyjRHF3xwRd32YdI1AVPRDDG0z0X_gsX49un6rKSmmNdtg7Pgdsiar6cJd7_rNnm8OH8YX5U3t5fX49Ob0gkBfamdqaSRnE4AvALOvANDmRNYcc9BS29M5RWCkw312klVKSZAcDQN1Wj4Nhkt985j9zZg6u0sJIfTad1iNyTLtNBZApdVRg_-oK_dENv8Xaak1JVWRmRKLikXu5QiejuPYVbHD0vBfhm2C8P2S59lzC4MW8i5_e_tw2SGzW_qR2kGTpYAZh3vAaNNLmDrsAkRXW-bLvxz4hOvMoaX</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>den Hartog, Gerco</creator><creator>van Kasteren, Puck B</creator><creator>Schepp, Rutger M</creator><creator>Teirlinck, Anne C</creator><creator>van der Klis, Fiona R M</creator><creator>van Binnendijk, Robert S</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>202301</creationdate><title>Decline of RSV-specific antibodies during the COVID-19 pandemic</title><author>den Hartog, Gerco ; van Kasteren, Puck B ; Schepp, Rutger M ; Teirlinck, Anne C ; van der Klis, Fiona R M ; van Binnendijk, Robert S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age groups</topic><topic>Antibodies</topic><topic>Antibodies, Neutralizing</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Immunity</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Pandemics</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory Syncytial Virus Infections - epidemiology</topic><topic>Respiratory Syncytial Virus, Human</topic><topic>Seasons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>den Hartog, Gerco</creatorcontrib><creatorcontrib>van Kasteren, Puck B</creatorcontrib><creatorcontrib>Schepp, Rutger M</creatorcontrib><creatorcontrib>Teirlinck, Anne C</creatorcontrib><creatorcontrib>van der Klis, Fiona R M</creatorcontrib><creatorcontrib>van Binnendijk, Robert S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>den Hartog, Gerco</au><au>van Kasteren, Puck B</au><au>Schepp, Rutger M</au><au>Teirlinck, Anne C</au><au>van der Klis, Fiona R M</au><au>van Binnendijk, Robert S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decline of RSV-specific antibodies during the COVID-19 pandemic</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2023-01</date><risdate>2023</risdate><volume>23</volume><issue>1</issue><spage>23</spage><epage>25</epage><pages>23-25</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>Lifting these measures resulted in out-of-season RSV activity, sometimes exceeding the incidence of hospitalisations observed in regular seasons.1–3 Declining immunity due to reduced exposure to the virus may contribute to this altered epidemiology.1,4,5 Bardsley and colleagues1 showed that the combination of laboratory, clinical, and syndromic data capture the impact of RSV activity, yet did not provide insight into the proposed decline in immunity. The repeated-measures general linear model (SPSS version 28; IBM, Armonk, NY, USA) was used to compare antibody concentrations between sampling timepoints of the same subjects and between age groups. p values, adjusted to Bonferroni and Benjamini-Hochberg procedures, are reported for timepoints and age-group differences respectively. [...]monitoring changes in antibody concentrations could identify populations susceptible to RSV infection.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>36463892</pmid><doi>10.1016/S1473-3099(22)00763-0</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2023-01, Vol.23 (1), p.23-25
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_2747007358
source Elsevier
subjects Age groups
Antibodies
Antibodies, Neutralizing
Coronaviruses
COVID-19
Epidemiology
Humans
Immunity
Infectious diseases
Laboratories
Pandemics
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus, Human
Seasons
title Decline of RSV-specific antibodies during the COVID-19 pandemic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A25%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decline%20of%20RSV-specific%20antibodies%20during%20the%20COVID-19%20pandemic&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=den%20Hartog,%20Gerco&rft.date=2023-01&rft.volume=23&rft.issue=1&rft.spage=23&rft.epage=25&rft.pages=23-25&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(22)00763-0&rft_dat=%3Cproquest_cross%3E2755787694%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-7c9859531b00f6032fc0912c4e83f3075f998f6e0c5d1f7c568624043e9d17e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2755787694&rft_id=info:pmid/36463892&rfr_iscdi=true